Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

British Journal of Rheumatology

Volumn 36, Issue 3, 1997, Pages 390-392

  Tyndall, A ^a   Gratwohl, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; DRUG THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SHORT SURVEY; STEM CELL TRANSPLANTATION; SURGERY;

AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 0030841034     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Breedveld FC, Struyk L, van Lear JM et al. Therapeutic regulation of T cells in rheumatoid arthritis. Immunol Rev 1995;144:5-16.
2. Brooks PM, Atkinson K, Hamilton JA. Stem cell transplantation in autoimmune disease. J Rheumatol 1995;221:1809-11.
3. Euler HH, Fastenrath S, Dreger P et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:in press.
4. Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood progenitor cell transplantation (PBSC-T) for the treatment of multiple sclerosis. Bone Marrow Transplant 17(suppl. 1):69a (Abstract).
5. Karussis DM, Slavin S, Ben Nun A et al. Chronic relapsing autoimmune encephalomyelitis (CR-EAR): treatment and induction of tolerance with high-dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 1992;39:200-1.
6. Liu Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992;9:31-3.
7. Marmont AM. Autoimmunity and allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;9:1-3.
8. Marmont A. In: Carella AM, ed. Autologous stem cell transplantation: biological and clinical results in malignancies. Amsterdam: Harwood Academic Press, 1996:441-50.
9. Marmont AM, van Bekkum DW. Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant 1995;16:497-8.
10. Marmont AM, Tyndall A, Gratwohl A, Vischer T. Haematopoietic precursor cell transplants for autoimmune diseases. Lancet 1995;345:978.
11. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-30.
12. Slavin S. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. Bone Marrow Transplant 1993;12:201-10.
13. Talal N. Oncogenes, autogenes, and rheumatic diseases. Arthritis Rheum 1994;37:1421-2.
14. Tyndall A, Gratwohl A. Haematopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996;35:149-151.
15. Van Bekkum D, Marmont A, Tyndall A, Vriesendorp F, Apatoff B, Rowlings P. Severe autoimmune diseases: A new target for bone marrow transplantation. Stem Cells 1996;14:460-72.
16. Van Gelder M, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995;16:343-51.